ES511302A0 - "METHOD FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING SILVER SULFADIAZINE AS AN ACTIVE SUBSTANCE". - Google Patents

"METHOD FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING SILVER SULFADIAZINE AS AN ACTIVE SUBSTANCE".

Info

Publication number
ES511302A0
ES511302A0 ES82511302A ES511302A ES511302A0 ES 511302 A0 ES511302 A0 ES 511302A0 ES 82511302 A ES82511302 A ES 82511302A ES 511302 A ES511302 A ES 511302A ES 511302 A0 ES511302 A0 ES 511302A0
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical compositions
active substance
compositions containing
containing silver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES82511302A
Other languages
Spanish (es)
Other versions
ES8307492A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lek Pharmaceuticals dd
Original Assignee
Lek Pharmaceuticals and Chemical Co dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals and Chemical Co dd filed Critical Lek Pharmaceuticals and Chemical Co dd
Publication of ES8307492A1 publication Critical patent/ES8307492A1/en
Publication of ES511302A0 publication Critical patent/ES511302A0/en
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ES82511302A 1981-09-22 1982-04-08 "METHOD FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING SILVER SULFADIAZINE AS AN ACTIVE SUBSTANCE". Granted ES511302A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU2274/81A YU44834B (en) 1981-09-22 1981-09-22 Process for preparing paste, based on silver sulfadiazine

Publications (2)

Publication Number Publication Date
ES8307492A1 ES8307492A1 (en) 1983-07-01
ES511302A0 true ES511302A0 (en) 1983-07-01

Family

ID=25557476

Family Applications (2)

Application Number Title Priority Date Filing Date
ES82511302A Granted ES511302A0 (en) 1981-09-22 1982-04-08 "METHOD FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING SILVER SULFADIAZINE AS AN ACTIVE SUBSTANCE".
ES83521394A Expired ES8404849A1 (en) 1981-09-22 1983-04-12 Method for the preparation of pharmaceutical compositions containing silver sulfadiazine as an active substance. (Machine-translation by Google Translate, not legally binding)

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES83521394A Expired ES8404849A1 (en) 1981-09-22 1983-04-12 Method for the preparation of pharmaceutical compositions containing silver sulfadiazine as an active substance. (Machine-translation by Google Translate, not legally binding)

Country Status (4)

Country Link
BE (1) BE892421A (en)
ES (2) ES511302A0 (en)
IT (1) IT1191172B (en)
YU (1) YU44834B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4045489A (en) * 1988-08-18 1990-03-23 Konrad Minninger Silver sulfadiazine containing pharmaceutical product for the local external therapy
US9433580B2 (en) 2011-07-21 2016-09-06 Sun Pharmaceutical Industries Limited Topical pharmaceutical composition comprising nanonized silver sulfadiazine
WO2012017349A2 (en) 2010-08-02 2012-02-09 Ranbaxy Laboratories Limited An improved topical pharmaceutical composition comprising nanonized silver sulfadiazine

Also Published As

Publication number Publication date
ES8307492A1 (en) 1983-07-01
IT8267343A0 (en) 1982-03-17
BE892421A (en) 1982-07-01
ES521394A0 (en) 1984-05-16
ES8404849A1 (en) 1984-05-16
IT1191172B (en) 1988-02-24
YU44834B (en) 1991-04-30
YU227481A (en) 1988-10-31

Similar Documents

Publication Publication Date Title
DE10075031I2 (en) Composition for the controlled release of an active ingredient.
ES522437A0 (en) PROCEDURE FOR THE PREPARATION OF SILVER CATALYSTS.
IT1190824B (en) PHARMACEUTICAL COMPOSITION CONTAINING 24.25-DIHYDROXICOLECALCIFEROL AS ACTIVE INGREDIENT
IT8222485A0 (en) PROCEDURE FOR THE MANUFACTURE OF CAGES FOR ROLLING BEARINGS.
IT8324035A0 (en) CEFEM COMPOUNDS WITH PHARMACEUTICAL ACTIVITY AND PROCEDURES FOR THEIR PREPARATION.
ES513672A0 (en) "PROCEDURE FOR THE PREPARATION OF PENEM DERIVATIVES".
ES513845A0 (en) "PROCEDURE FOR THE PREPARATION OF NEW 2-AMINO-CARBOXYLIC ACID DERIVATIVES".
FR2567519B1 (en) NOVEL ISOINDOLINYL-ALCOYL-PIPERAZINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION
IT8323058A0 (en) BIOLOGICALLY ACTIVE 2,5-PIPERAZINDION DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
FR2518091B1 (en) 23-DEHYDRO-25-HYDROXYVITAMINE D3, ITS PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
IT1213173B (en) ANTIBACTERIAL ACTIVITY COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
ES511302A0 (en) "METHOD FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING SILVER SULFADIAZINE AS AN ACTIVE SUBSTANCE".
BE892292A (en) BIOLOGICALLY ACTIVE SUBSTANCE, PROCESS FOR PREPARING THE SAME, AND IMMUNOACTIVE COMPOSITION
ES514274A0 (en) "PROCEDURE FOR THE PREPARATION OF BENZOTRIAZOLES".
ES523695A0 (en) PREPARATION PROCEDURE FOR RACEMICAL OR OPTIMALLY ACTIVE EBURNANO-OXIMA DERIVATIVES.
FR2604707B1 (en) PROCESS FOR THE PREPARATION OF AN ACTIVE THERAPEUTIC COMPOUND
FR2567402B1 (en) NOVEL PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING DIHYDROXY-1,8 PHENYL-10 ANTHRONE-9 AS ACTIVE INGREDIENT, AND PROCESS FOR PREPARING THE ACTIVE INGREDIENT
IT8121298A0 (en) NITROIMIDAZOLES WITH TRICOMONACID ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
NO164599C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 7-D-MANDELAMIDO-3- (1-SULPHOMETHYL-TETRAZOL-5-YL) -TIOMETHYL-3-CEFEM-4-CARBOXYLIC ACID MONONATRUM SALT.
ES511134A0 (en) "PROCEDURE FOR THE PREPARATION OF NEW HYDRAZINE DERIVATIVES, USEFUL AS FUNGICIDES AND BACTERICIDES".
IT8222339A0 (en) COMPOUNDS WITH CALCIUM-ANTAGONIST ACTIVITY, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS.
IT8520514A0 (en) COMPOSITIONS OF DRUG EQUIPPED WITH ANTIMICROBIAL ACTIVITY AND PROCEDURE FOR THEIR PREPARATION.
ES513482A0 (en) "PERFECTED PREPARATION PROCEDURE OF 2,4-DIAMINO-5- (3 ', 4', 5'-TRIMETOXI-BENCIL) -PIRIMIDINE".
IT8520515A0 (en) COMPOSITIONS OF DRUG AND PROCEDURE FOR THEIR PREPARATION.
IT8421627A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING THE ACTIVE INGREDIENT 24,25-DIIDROXYCHOLECALCIFEROL